Knightsbridge Asset Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.33M Buy
17,600
+38
+0.2% +$19.1K 1.12% 18
2025
Q4
$8.2M Sell
17,562
-475
-3% -$221K 1.32% 16
2025
Q3
$7.69M Buy
18,037
+137
+0.8% +$53.1K 1.3% 22
2025
Q2
$6.86M Buy
17,900
+25
+0.1% +$9.01K 1.51% 23
2025
Q1
$6.18M Sell
17,875
-484
-3% -$156K 1.59% 20
2024
Q4
$5.51M Sell
18,359
-22
-0.1% -$7.69K 1.28% 28
2024
Q3
$7.47M Buy
18,381
+93
+0.5% +$34K 1.68% 23
2024
Q2
$5.88M Buy
18,288
+96
+0.5% +$31.2K 1.46% 29
2024
Q1
$4.92M Hold
18,192
1.39% 28
2023
Q4
$4.92M Sell
18,192
-825
-4% -$204K 1.39% 28
2023
Q3
$4.68M Sell
19,017
-558
-3% -$153K 1.47% 31
2023
Q2
$5.94M Sell
19,575
-19,312
-50% -$5.37M 1.91% 19
2023
Q1
$10.3M Buy
38,887
+163
+0.4% +$41.4K 1.75% 23
2022
Q4
$9.29M Buy
38,724
+132
+0.3% +$29.6K 1.76% 22
2022
Q3
$7.09M Sell
38,592
-625
-2% -$125K 1.49% 31
2022
Q2
$6.59M Buy
39,217
+19,406
+98% +$4.17M 1.31% 31
2022
Q1
$4.96M Buy
19,811
+133
+0.7% +$33.4K 1.66% 22
2021
Q4
$5.06M Sell
19,678
-21,249
-52% -$5.2M 1.68% 26
2021
Q3
$9.93M Sell
40,927
-1,234
-3% -$302K 3.5% 7
2021
Q2
$8.72M Buy
42,161
+606
+1% +$124K 3.39% 13
2021
Q1
$7.83M Sell
41,555
-1,418
-3% -$250K 3.31% 14
2020
Q4
$7.07M Sell
42,973
-4,308
-9% -$630K 3.46% 16
2020
Q3
$5.89M Sell
47,281
-684
-1% -$84.7K 3.39% 18
2020
Q2
$4.66M Buy
47,965
+320
+0.7% +$33.3K 3.01% 19
2020
Q1
$4.28M Sell
47,645
-1,376
-3% -$178K 4.31% 14
2019
Q4
$7.25M Buy
49,021
+128
+0.3% +$17.2K 5.53% 9
2019
Q3
$5.89M Sell
48,893
-52,422
-52% -$6.77M 4.62% 12
2019
Q2
$13.7M Buy
101,315
+29,114
+40% +$3.68M 9.44% 1
2019
Q1
$9.41M Sell
72,201
-34,233
-32% -$4.6M 7.19% 4
2018
Q4
$13.2M Sell
106,434
-2,747
-3% -$369K 9.74% 2
2018
Q3
$15.2M Sell
109,181
-40
-0% -$4.98K 9.41% 1
2018
Q2
$11.2M Sell
109,221
-1,200
-1% -$121K 6.96% 1
2018
Q1
$10.7M Buy
+110,421
New +$10.7M 6.66% 4

Other funds holding HCA

Knightsbridge Asset Management's HCA Position: Q1 2026 in Review

Knightsbridge Asset Management increased its HCA Healthcare (HCA) stake by 0.22% in Q1 2026, buying an estimated $19.1K and bringing the position to 17,600 shares worth $8.33M. The position accounts for 1.12% of the portfolio, ranked #18.

Knightsbridge Asset Management first reported a position in HCA in Q1 2018 and has held it in 33 quarters since. The position peaked at $15.2M in Q3 2018. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Knightsbridge Asset Management held 17,600 shares of HCA Healthcare worth $8.33M as of Q1 2026.
  • Knightsbridge Asset Management bought 38 HCA Healthcare shares in Q1 2026, an estimated $19.1K.
  • HCA Healthcare made up 1.12% of Knightsbridge Asset Management's portfolio in Q1 2026, its #18 holding.
  • Knightsbridge Asset Management first reported a position in HCA Healthcare in Q1 2018 and has held it in 33 quarters since.
  • Knightsbridge Asset Management's HCA Healthcare position peaked at $15.2M in Q3 2018.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Knightsbridge Asset Management's 13F filing for Q1 2026, filed 15 May 2026.